Citigroup
NVO

Citigroup’s Novo Nordisk NVO Stock Holding History

Citigroup’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56.9M Buy
1,547,655
+141,931
+10% +$6.72M 0.02% 592
2025
Q4 		$71.5M Buy
1,405,724
+915,240
+187% +$46.8M 0.03% 494
2025
Q3 		$27.2M Sell
490,484
-660,486
-57% -$38.7M 0.01% 903
2025
Q2 		$79.4M Sell
1,150,970
-95,438
-8% -$6.49M 0.04% 412
2025
Q1 		$86.6M Sell
1,246,408
-365,158
-23% -$30.2M 0.04% 361
2024
Q4 		$139M Buy
1,611,566
+252,412
+19% +$27.3M 0.08% 216
2024
Q3 		$162M Buy
1,359,154
+28,707
+2% +$3.83M 0.09% 189
2024
Q2 		$190M Buy
1,330,447
+22,164
+2% +$2.94M 0.12% 158
2024
Q1 		$168M Buy
1,308,283
+731,539
+127% +$87.1M 0.11% 173
2023
Q4 		$59.7M Buy
576,744
+5,475
+1% +$541K 0.04% 395
2023
Q3 		$52M Buy
571,269
+48,783
+9% +$4.3M 0.04% 412
2023
Q2 		$42.3M Buy
522,486
+7,618
+1% +$622K 0.03% 501
2023
Q1 		$41M Buy
514,868
+10,704
+2% +$759K 0.03% 480
2022
Q4 		$34.1M Buy
504,164
+70,148
+16% +$4.11M 0.03% 544
2022
Q3 		$21.6M Sell
434,016
-2,034
-0.5% -$109K 0.02% 749
2022
Q2 		$24.3M Buy
436,050
+111,702
+34% +$6.2M 0.02% 707
2022
Q1 		$18M Buy
324,348
+30,080
+10% +$1.54M 0.01% 998
2021
Q4 		$16.5M Buy
294,268
+61,960
+27% +$3.36M 0.01% 1107
2021
Q3 		$11.2M Sell
232,308
-74,142
-24% -$3.58M 0.01% 1340
2021
Q2 		$12.8M Buy
306,450
+9,844
+3% +$382K 0.01% 1263
2021
Q1 		$10M Buy
296,606
+15,678
+6% +$558K 0.01% 1371
2020
Q4 		$9.81M Sell
280,928
-15,558
-5% -$538K 0.01% 1566
2020
Q3 		$10.3M Buy
296,486
+20,942
+8% +$698K 0.01% 1357
2020
Q2 		$9.02M Buy
275,544
+17,922
+7% +$572K 0.01% 1380
2020
Q1 		$7.75M Sell
257,622
-39,198
-13% -$1.17M 0.01% 1332
2019
Q4 		$8.59M Buy
296,820
+137,930
+87% +$3.82M 0.01% 1606
2019
Q3 		$4.11M Buy
158,890
+22,330
+16% +$565K ﹤0.01% 2118
2019
Q2 		$3.49M Buy
136,560
+25,796
+23% +$638K ﹤0.01% 2272
2019
Q1 		$2.9M Sell
110,764
-19,432
-15% -$478K ﹤0.01% 2260
2018
Q4 		$3M Buy
130,196
+1,284
+1% +$28.5K ﹤0.01% 2297
2018
Q3 		$3.04M Sell
128,912
-58,612
-31% -$1.43M ﹤0.01% 2326
2018
Q2 		$4.33M Sell
187,524
-26,090
-12% -$620K ﹤0.01% 1975
2018
Q1 		$5.25M Buy
213,614
+17,216
+9% +$452K ﹤0.01% 1706
2017
Q4 		$5.27M Buy
196,398
+35,320
+22% +$898K ﹤0.01% 1786
2017
Q3 		$3.88M Sell
161,078
-177,706
-52% -$4.02M ﹤0.01% 2005
2017
Q2 		$7.27M Buy
338,784
+118,856
+54% +$2.4M 0.01% 1402
2017
Q1 		$3.77M Sell
219,928
-94,120
-30% -$1.64M ﹤0.01% 1887
2016
Q4 		$5.63M Sell
314,048
-518,030
-62% -$9.39M 0.01% 1707
2016
Q3 		$17.3M Buy
832,078
+420,660
+102% +$10.4M 0.02% 766
2016
Q2 		$11.1M Buy
411,418
+10,508
+3% +$288K 0.01% 986
2016
Q1 		$10.9M Sell
400,910
-99,098
-20% -$2.65M 0.01% 952
2015
Q4 		$14.5M Sell
500,008
-44,830
-8% -$1.24M 0.01% 908
2015
Q3 		$14.8M Sell
544,838
-38,482
-7% -$1.09M 0.01% 879
2015
Q2 		$16M Buy
583,320
+18,762
+3% +$527K 0.01% 920
2015
Q1 		$15.1M Buy
564,558
+100,588
+22% +$2.32M 0.01% 930
2014
Q4 		$9.82M Sell
463,970
-14,416
-3% -$322K 0.01% 1289
2014
Q3 		$11.4M Sell
478,386
-4,728
-1% -$109K 0.01% 1185
2014
Q2 		$11.2M Sell
483,114
-117,024
-19% -$2.58M 0.01% 1186
2014
Q1 		$13.7M Buy
600,138
+72,138
+14% +$1.54M 0.01% 954
2013
Q4 		$9.76M Buy
528,000
+33,260
+7% +$580K 0.01% 1271
2013
Q3 		$8.37M Buy
494,740
+29,660
+6% +$499K 0.01% 1321
2013
Q2 		$7.21M Buy
+465,080
New +$7.74M 0.01% 1334

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Citigroup's NVO Position: Q1 2026 in Review

Citigroup increased its Novo Nordisk (NVO) stake by 10% in Q1 2026, buying an estimated $6.72M and bringing the position to 1,547,655 shares worth $56.9M. The position accounts for 0.02% of the portfolio, ranked #592.

Citigroup first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $190M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Citigroup held 1,547,655 shares of Novo Nordisk worth $56.9M as of Q1 2026.
  • Citigroup bought 141,931 Novo Nordisk shares in Q1 2026, an estimated $6.72M.
  • Novo Nordisk made up 0.02% of Citigroup's portfolio in Q1 2026, its #592 holding.
  • Citigroup first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Novo Nordisk position peaked at $190M in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.